FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387333521> ?p ?o ?g. }

• W4387333521 abstract "This study is aimed to synthesize morpholine- and thiazolidine-based novel 5-(substituted)benzylidene)-2-(morpholinoimino)-3-phenylthiazolidin-4-ones (3–26) and characterized by molecular spectroscopy. The synthesized compounds were subjected to antioxidant activity with anticholinesterase, tyrosinase, and urease inhibition activities and evaluated the structure–activity relationship (SAR) of enzyme inhibition activities. Compound 11 was found to be the most active antioxidant. In anticholinesterase inhibition, compound 12 (IC50: 17.41 ± 0.22 μM) was the most active against AChE, while compounds 3–26 ( except 3, 8, and 17) showed notable activity against BChE. Compounds 17 (IC50: 3.22 ± 0.70 mM), 15 (IC50: 5.19 ± 0.03 mM), 24 (IC50: 7.21 ± 0.27 mM), 23 (IC50: 8.05 ± 0.11 mM), 14 (IC50: 8.10 ± 0.22 mM), 25 (IC50: 8.40 ± 0.64 mM), 26 (IC50: 8.76 ± 0.90 mM), and 22 (IC50: 9.13 ± 0.55 mM) produced higher tyrosinase inhibition activity. In urease inhibition activity, compounds 20 (IC50: 16.79 ± 0.19 μM), 19 (IC50: 18.25 ± 0.50 μM), 18 (IC50: 20.24 ± 0.77 μM), 26 (IC50: 21.51 ± 0.44 μM), 25 (IC50: 21.70 ± 0.06 μM), and 24 (IC50: 22.49 ± 0.11 μM) demonstrated excellent activities. Besides, the molecular docking study was applied to better understand the inhibitory mechanism between (1–26) compounds and enzymes at the molecular level. According to the results of this study, the synthesized compounds exhibited a better binding affinity toward these enzymes compared to the positive control. Further, molecular mechanics Poisson–Boltzmann surface area (MM/PBSA) binding free energy and molecular dynamics (MD) simulation analyses were performed for AChE with compound 26, which showed high inhibitory activity in silico and in vitro studies. In conclusion, novel morpholine and thiazolidine-based derivative compounds may be pharmacologically effective agents for AChE, BChE, tyrosinase, and urease enzymes." @default.
• W4387333521 created "2023-10-05" @default.
• W4387333521 creator A5017612360 @default.
• W4387333521 creator A5019699603 @default.
• W4387333521 creator A5040874528 @default.
• W4387333521 creator A5048599051 @default.
• W4387333521 creator A5050644899 @default.
• W4387333521 creator A5077690347 @default.
• W4387333521 creator A5091044841 @default.
• W4387333521 date "2023-10-04" @default.
• W4387333521 modified "2023-10-14" @default.
• W4387333521 title "Design, Synthesis, Pharmacological Activities, Structure–Activity Relationship, and In Silico Studies of Novel 5-Substituted-2-(morpholinoimino)-thiazolidin-4-ones" @default.
• W4387333521 cites W1523213544 @default.
• W4387333521 cites W1577601626 @default.
• W4387333521 cites W1592062002 @default.
• W4387333521 cites W16376535 @default.
• W4387333521 cites W1826417692 @default.
• W4387333521 cites W1873597045 @default.
• W4387333521 cites W1912217738 @default.
• W4387333521 cites W1966485019 @default.
• W4387333521 cites W1969046853 @default.
• W4387333521 cites W1971048984 @default.
• W4387333521 cites W1973425278 @default.
• W4387333521 cites W1977182996 @default.
• W4387333521 cites W1987170637 @default.
• W4387333521 cites W1992544322 @default.
• W4387333521 cites W1998395681 @default.
• W4387333521 cites W2000583301 @default.
• W4387333521 cites W2002208507 @default.
• W4387333521 cites W2012991711 @default.
• W4387333521 cites W2013132270 @default.
• W4387333521 cites W2013484094 @default.
• W4387333521 cites W2013501171 @default.
• W4387333521 cites W2031596649 @default.
• W4387333521 cites W2034880630 @default.
• W4387333521 cites W2044010050 @default.
• W4387333521 cites W2044172327 @default.
• W4387333521 cites W2046588215 @default.
• W4387333521 cites W2047603589 @default.
• W4387333521 cites W2050376207 @default.
• W4387333521 cites W2053984137 @default.
• W4387333521 cites W2058844545 @default.
• W4387333521 cites W2067987271 @default.
• W4387333521 cites W2070753604 @default.
• W4387333521 cites W2073532176 @default.
• W4387333521 cites W2083070139 @default.
• W4387333521 cites W2105668062 @default.
• W4387333521 cites W2109154308 @default.
• W4387333521 cites W2116531314 @default.
• W4387333521 cites W2118970241 @default.
• W4387333521 cites W2119158234 @default.
• W4387333521 cites W2120701384 @default.
• W4387333521 cites W2135134122 @default.
• W4387333521 cites W2144868623 @default.
• W4387333521 cites W2162730446 @default.
• W4387333521 cites W2166993966 @default.
• W4387333521 cites W2169152986 @default.
• W4387333521 cites W2183050958 @default.
• W4387333521 cites W2248724860 @default.
• W4387333521 cites W2269817928 @default.
• W4387333521 cites W2274192589 @default.
• W4387333521 cites W2520394603 @default.
• W4387333521 cites W2731784911 @default.
• W4387333521 cites W2758083153 @default.
• W4387333521 cites W2765327324 @default.
• W4387333521 cites W2899882656 @default.
• W4387333521 cites W2903336324 @default.
• W4387333521 cites W2938255671 @default.
• W4387333521 cites W2950676432 @default.
• W4387333521 cites W2989795769 @default.
• W4387333521 cites W3041731933 @default.
• W4387333521 cites W3048109577 @default.
• W4387333521 doi "https://doi.org/10.1021/acsomega.3c05928" @default.
• W4387333521 hasPublicationYear "2023" @default.
• W4387333521 type Work @default.
• W4387333521 citedByCount "0" @default.
• W4387333521 crossrefType "journal-article" @default.
• W4387333521 hasAuthorship W4387333521A5017612360 @default.
• W4387333521 hasAuthorship W4387333521A5019699603 @default.
• W4387333521 hasAuthorship W4387333521A5040874528 @default.
• W4387333521 hasAuthorship W4387333521A5048599051 @default.
• W4387333521 hasAuthorship W4387333521A5050644899 @default.
• W4387333521 hasAuthorship W4387333521A5077690347 @default.
• W4387333521 hasAuthorship W4387333521A5091044841 @default.
• W4387333521 hasBestOaLocation W43873335211 @default.
• W4387333521 hasConcept C159110408 @default.
• W4387333521 hasConcept C181199279 @default.
• W4387333521 hasConcept C185592680 @default.
• W4387333521 hasConcept C202751555 @default.
• W4387333521 hasConcept C2777752497 @default.
• W4387333521 hasConcept C2778004101 @default.
• W4387333521 hasConcept C41685203 @default.
• W4387333521 hasConcept C55493867 @default.
• W4387333521 hasConcept C71240020 @default.
• W4387333521 hasConcept C71924100 @default.
• W4387333521 hasConcept C87554066 @default.
• W4387333521 hasConceptScore W4387333521C159110408 @default.
• W4387333521 hasConceptScore W4387333521C181199279 @default.
• W4387333521 hasConceptScore W4387333521C185592680 @default.
• W4387333521 hasConceptScore W4387333521C202751555 @default.

• next